EMA - Accelerating Clinical Trials in the EU (ACT EU): for better clinical trials that address patients’ needs - Joint Press Release

25th January 2022

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) are coming together to optimise the environment for clinical research in Europe by launching Accelerating Clinical Trials in the EU (ACT EU).

This initiative will use the momentum of the incoming Clinical Trials Regulation on 31 January to further promote the development of high quality, safe and effective medicines.

One of the initiative’s priority actions will be to establish a multistakeholder platform, where all voices, including those of patients can contribute to enabling better clinical research.

To find out more please click here for the joint press release on ACT EU.

Back to News Archive